Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred W Rademaker

Showing results (91-100 of 164) with videos related to

Pageof 17
Sort By:
Free Radical Biology & Medicine|July 19, 2016
Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivityRichard C Miller, Jeffrey S Murley, Alfred W Rademaker, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2017
Intensive Care Unit Outcomes Among Patients With Cancer After Palliative Radiation TherapyJacqueline M Kruser, Sunpreet S Rakhra, Ryan M Sacotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
In vivo generation of angiostatin isoforms by administration of a plasminogen activator and a free sulfhydryl donor: a phase I study of an angiostatic cocktail of tissue plasminogen activator and mesnaGerald A Soff, Hao Wang, Deborah L Cundiff, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
A comprehensive quality assurance program for personnel and procedures in radiation oncology: value of voluntary error reporting and checklistsJohn A Kalapurakal, Aleksandar Zafirovski, Jeffery Smith, et al.
Journal of the American Academy of Dermatology|February 1, 2016
The utility of dermoscopy-guided histologic sectioning for the diagnosis of melanocytic lesions: A case-control studyEmily A Merkel, Sapna M Amin, Christina Y Lee, et al.
Dysphagia|September 24, 2004
Beyond efficacy and effectiveness: conducting economic analyses during clinical trialsTeresa M Waters, Jeri A Logemann, Barbara Roa Pauloski, et al.
Radiation Oncology (London, England)|May 1, 2015
Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapyTarita O Thomas, Tamer Refaat, Mehee Choi, et al.
Oncotarget|November 21, 2017
The non-canonical ubiquitin activating enzyme UBA6 suppresses epithelial-mesenchymal transition of mammary epithelial cellsXianpeng Liu, Limin Sun, Demirkan B Gursel, et al.
BMC Ophthalmology|December 31, 2016
Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trialAngelo P Tanna, Alfred W Rademaker, C Gustavo de Moraes, et al.
The Oncologist|August 7, 2014
Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review studyJonathan R Strosberg, Al B Benson, Lynn Huynh, et al.
Pageof 17

Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
Free Radical Biology & Medicine|July 19, 2016
Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivityRichard C Miller, Jeffrey S Murley, Alfred W Rademaker, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2017
Intensive Care Unit Outcomes Among Patients With Cancer After Palliative Radiation TherapyJacqueline M Kruser, Sunpreet S Rakhra, Ryan M Sacotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
In vivo generation of angiostatin isoforms by administration of a plasminogen activator and a free sulfhydryl donor: a phase I study of an angiostatic cocktail of tissue plasminogen activator and mesnaGerald A Soff, Hao Wang, Deborah L Cundiff, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
A comprehensive quality assurance program for personnel and procedures in radiation oncology: value of voluntary error reporting and checklistsJohn A Kalapurakal, Aleksandar Zafirovski, Jeffery Smith, et al.
Journal of the American Academy of Dermatology|February 1, 2016
The utility of dermoscopy-guided histologic sectioning for the diagnosis of melanocytic lesions: A case-control studyEmily A Merkel, Sapna M Amin, Christina Y Lee, et al.
Dysphagia|September 24, 2004
Beyond efficacy and effectiveness: conducting economic analyses during clinical trialsTeresa M Waters, Jeri A Logemann, Barbara Roa Pauloski, et al.
Radiation Oncology (London, England)|May 1, 2015
Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapyTarita O Thomas, Tamer Refaat, Mehee Choi, et al.
Oncotarget|November 21, 2017
The non-canonical ubiquitin activating enzyme UBA6 suppresses epithelial-mesenchymal transition of mammary epithelial cellsXianpeng Liu, Limin Sun, Demirkan B Gursel, et al.
BMC Ophthalmology|December 31, 2016
Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trialAngelo P Tanna, Alfred W Rademaker, C Gustavo de Moraes, et al.
The Oncologist|August 7, 2014
Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review studyJonathan R Strosberg, Al B Benson, Lynn Huynh, et al.
Pageof 17